Clinical Trials Logo
  1. Home
  2. End Stage Renal Disease
  3. NCT01101217
  4. Details
NCT01101217 Clinical Trial

Effect of Zinc Suplementation on Serum Hemosystein Level in Hemodialysis Patients

End Stage Renal Failure Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT01101217
Other study ID # 4542
Secondary ID
Status Completed
Phase N/A
First received April 8, 2010
Last updated April 8, 2010
Start date February 2009
Est. completion date September 2009

Study information
Verified date January 2009
Source Shiraz University of Medical Sciences
Contact n/a
Is FDA regulated No
Health authority Iran: Ministry of Health
Study type Interventional

Clinical Trial Summary

The purpose of this study is to study the effect of zinc supplementation in end stage renal failure on hemocystein level.

Description:

hemocystein increased in end stage renal failure and zinc involved in hemocystein metabolism thus zinc supplementation may be effective on hemocystein level.

Recruitment information / eligibility
Status Completed
Enrollment 100
Est. completion date September 2009
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- hemodialysis for 3 months

- older than 18 years old

- serum level of zinc less than 72.6 microgram/ l in men and less than 70 microgram/ l in female

Exclusion Criteria:

- acute renal failre

- malabsorption

- history of steroid or cytotoxic consumption

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Intervention

Drug:
• Zinc Supplement
in 50 patients zinc sulfate 220 mg per day orally for 6 weeks
• placebo
placebo daily for 6 weeks

Locations
Country Name City State
Iran, Islamic Republic of Shiraz University Hemodialysis Center Shiraz, Fars

Sponsors (1)
Lead Sponsor Collaborator
Shiraz University of Medical Sciences

Country where clinical trial is conducted

Iran, Islamic Republic of, 

Outcome
Type Measure Description Time frame Safety issue
Primary decreased hemocystein level 6 months Yes
See also
  Status Clinical Trial Phase
Completed NCT01766882 - Volume,Sodium and Blood Pressure Management in HD N/A
Completed NCT01037595 - Effect of Turmeric on Pruritus in Hemodialysis Patients Phase 0
Completed NCT02686398 - Immunogenicity of a Trivalent Influenza Vaccine in Chronic Kidney Disease Patients Undergoing Hemodialysis Phase 4
Active, not recruiting NCT04376567 - Outcomes for One-stage and Two-stage Brachial Basilic Arteriovenous Fistulas N/A
Completed NCT01990118 - Gengraf Conversion Study in Stable Renal Allograft Transplant Recipients Phase 4
Recruiting NCT01704313 - A Trial of Interrupted vs Continuous Suturing Techniques for Radiocephalic Fistulae N/A
Not yet recruiting NCT06389617 - Different Doses of Intravenous Administered Dexamethasone Effecting Brachial Plexus Supraclavicular Block N/A
Completed NCT01004627 - A Study of Routine Versus Selective Use of Ultrasound Scanning Prior to Haemodialysis Fistula Surgery N/A
Recruiting NCT02895425 - Registry for End Stage Renal Failure N/A
Not yet recruiting NCT02341547 - Effectiveness of a Biosimilar Epoetin Alfa in Stable 'End Stage Renal Failure' N/A
Completed NCT01834755 - Physical and Psychological Profiles Associated With Patient's Preference for ESRD Treatment N/A
Completed NCT01996930 - Steroid Impregnated Tape in the Treatment of Over-granulating Peritoneal Dialysis Exit Sites Phase 3
Not yet recruiting NCT01704339 - Qutenza for Critical Ischaemia in End Stage Renal Failure Phase 4
Recruiting NCT01781156 - Effect of Reducing Phosphorus Absorption on Cardiac Biomarkers in Hemodialysis Patients N/A
Completed NCT01906840 - Role of Turmeric on Oxidative Modulation in ESRD Patients Phase 1/Phase 2
Not yet recruiting NCT06378931 - Quality of Life Change in Patients Undergoing Parathyroidectomy With End-stage Renal Failure